ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EMA approves Cimzia for use in treating plaque psoriasis
pharmafile
July 06, 2018The Brussels-based pharmaceutical company UCB has announced that the European Medicines Agency (EMA) has approved a label extension for Cimzia (certolizumab pegol), to include a new indication in adult patients with moderate-to-severe plaque psoriasis.
Pharma Sources Insight January 2025
